The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Uk Small Regulatory News (AUSC)

Share Price Information for Abrdn Uk Small (AUSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 463.50
Bid: 462.00
Ask: 463.50
Change: 0.00 (0.00%)
Spread: 1.50 (0.325%)
Open: 463.50
High: 463.50
Low: 457.00
Prev. Close: 463.50
AUSC Live PriceLast checked at -
abrdn UK Smaller Companies Growth is an Investment Trust

To achieve long term capital growth by investment in UK quoted smaller companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on abrdn UK Smaller Companies Growth Trust (AUSC): Performance setback providing good entry point?

19 Oct 2023 09:07

Edison Investment Research Limited Edison issues review on abrdn UK Smaller Companies Growth Trust (AUSC): Performance setback providing good entry point? 19-Oct-2023 / 09:06 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 19 October 2023

 

Edison issues review on abrdn UK Smaller Companies Growth Trust (AUSC): Performance setback providing good entry point?

abrdn UK Smaller Companies Growth Trust (AUSC) is managed by Abby Glennie and Amanda Yeaman. The strategy of using the proprietary Matrix screening tool to search for stocks that fulfil strict quality, growth and momentum criteria has proved very successful over the long term but has been challenged since the start of 2022, as macroeconomic factors rather than company fundamentals have driven stock markets. Despite their frustrations, the managers are sticking with their tried-and-tested strategy and are highly confident that the trust will resume its record of outperformance when there is a change in the investment backdrop. This may already be underway as UK inflation is moderating, interest rates may be close to peaking and, in recent months, AUSC’s NAV performance versus the reference index looks to have stabilised.

 

Despite the trust’s performance, the managers highlight that, at the fundamental level, AUSC’s prospects are bright. Its top 10 holdings are a diverse mix of businesses and, at 31 August 2023, seven companies had upwards earnings trends, while three were flat. The trust’s portfolio offers a broad exposure to both international growth (51% of total revenue) and domestic (49%), which includes dominant UK operators and global leaders, or those companies able to expand into adjacent businesses or geographies.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors – Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1752809 19-Oct-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Apr 20245:24 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20245:28 pmRNSTransaction in Own Shares
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:42 pmRNSTransaction in Own Shares
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:21 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20245:14 pmRNSTransaction in Own Shares
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:20 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 20245:12 pmRNSTransaction in Own Shares
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:30 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20243:45 pmRNSInvestor Presentation - 10am, 21 May 2024
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20245:10 pmRNSTransaction in Own Shares
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:47 pmRNSNet Asset Value(s)
12th Apr 20245:25 pmRNSTransaction in Own Shares
12th Apr 202412:56 pmRNSNet Asset Value(s)
11th Apr 20245:14 pmRNSTransaction in Own Shares
11th Apr 202412:41 pmRNSNet Asset Value(s)
10th Apr 20245:27 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 20245:21 pmRNSTransaction in Own Shares
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:19 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20245:21 pmRNSQuarterly disclosure
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20245:24 pmRNSTransaction in Own Shares
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:14 amRNSTotal Voting Rights
28th Mar 20245:41 pmRNSTransaction in Own Shares
28th Mar 20243:15 pmRNSNet Asset Value(s)
27th Mar 20245:21 pmRNSTransaction in Own Shares
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 20245:13 pmRNSTransaction in Own Shares
26th Mar 202412:23 pmRNSNet Asset Value(s)
25th Mar 20245:36 pmRNSTransaction in Own Shares
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 202412:16 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.